Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05899660
NA

Impact of Omega 3 in Alcohol Use Disorder

Sponsor: Université Catholique de Louvain

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to investigate the biological pathways underlying the beneficial effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) on mental health in patients with alcohol use disorder. The main questions this study aims to answer are: * Can n-3 PUFA improve mood disorders (depression, anxiety), craving for alcohol, cognitive impairments and sociability disorders ? * Are the beneficial effects of n-3 PUFAs due to a modification of the gut microbiota and/or the inflammatory status? Participants will : * take a supplementation of omega-3 or placebo during 3 months * do a brain MRI * be interviewed for a dietary anamnesis * provide blood, stool and saliva samples * perform psychological tests and neuropsychological tasks Researchers will compare active comparator (omega-3) with placebo comparator (olive oil) to see if omega-3 can have a beneficial effect on AUD patients.

Official title: Impact of Omega-3 Polyunsaturated Fatty Acids on Emotional, Cognitive and Biological Alterations in Alcohol Use Disorder

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-06-19

Completion Date

2027-12-31

Last Updated

2023-06-22

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Active Comparator: Omega-3

It is a dietary supplement made of fish oil rich in n-3 PUFA.

DIETARY_SUPPLEMENT

Placebo Comparator: olive oil

Refined olive oil is the usual placebo used in studies with n-3 PUFA.

Locations (1)

Cliniques universitaires Saint Luc

Brussels, Belgium